SCHEMBL4148374

SCHEMBL4148374

NS(=O)(=O)c1ccc(CNc2nccc(-c3cccnc3)n2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 7/20 0.64
HDAC2 Q92769 6/20 0.64
NCOR1 O75376 6/20 0.64
HDAC1 Q13547 5/20 0.64
HDAC6 Q9UBN7 3/20 0.64
HDAC8 Q9BY41 2/20 0.64
IKBKB O14920 3/20 0.58
CYP3A4 P08684 1/20 0.58
HDAC11 Q96DB2 1/20 0.58
NCOR2 Q9Y618 1/20 0.58
CA1 P00915 4/20 0.53
CA2 P00918 4/20 0.53
CA9 Q16790 4/20 0.53
CA12 O43570 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
ABL1 P00519 1/20 0.51
EGFR P00533 1/20 0.51
PRKCA P17252 1/20 0.51
PRKCD Q05655 1/20 0.51
DKK1 O94907 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4154191 0.86 IKBKB (0.55) IKBKBCA1CA2CA9CA12
SCHEMBL7470673 0.84 IKBKB (0.81) IKBKBCA2ABL1EGFRPRKCA
SCHEMBL19015114 0.83 HDAC3 (0.69) HDAC3HDAC2NCOR1HDAC1HDAC6
SCHEMBL3647596 0.81 DKK1 (0.72) IKBKBCA1CA2CA9CA12
SCHEMBL29784912 0.81 HDAC3 (0.77) HDAC3HDAC2NCOR1HDAC1HDAC6
SCHEMBL1067828 0.80 HDAC3 (0.79) HDAC3HDAC2NCOR1HDAC1HDAC6
SCHEMBL27782645 0.78 HDAC3 (0.69) HDAC3HDAC2NCOR1HDAC1HDAC6
SCHEMBL4147267 0.78 KDM4E (0.52) IKBKBCYP3A4CA1CA2CA9
SCHEMBL1926503 0.77 PDGFRA (0.64) HDAC3HDAC2HDAC1HDAC6HDAC8
SCHEMBL1065202 0.77 HDAC3 (0.74) HDAC3HDAC2NCOR1HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090048282-A1 PYRIMIDINE SULFONAMIDE ANALOGS AND THEIR USE AS AGONISTS OF THE WNT-BETA-CATENIN CELLULAR MESSAGING SYSTEM WYETH (US) 2009-02-19 US claimed
US-20090048282-A1 PYRIMIDINE SULFONAMIDE ANALOGS AND THEIR USE AS AGONISTS OF THE WNT-BETA-CATENIN CELLULAR MESSAGING SYSTEM WYETH (US) 2009-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090048282-A1 PYRIMIDINE SULFONAMIDE ANALOGS AND THEIR USE AS AGONISTS OF THE WNT-BETA-CATENIN CELLULAR MESSAGING SYSTEM WNT1, CTNNB1, WNT3A HDAC3 4538/4885HDAC2 4785/4885NCOR1 646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.